Impact of pneumococcal vaccination in children in the distribution of serotypes in bacteriemic pneumococcal pneumonia in adults Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis Year: 2017
Clinical presentations and serotypes causing invasive pneumococcal disease in adults vaccinated with the 23-valent polysaccharide pneumococcal vaccine (PPV23) in Spain. The ODIN study (2010-2013) Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014
Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia Source: Eur Respir J 2010; 36: 1073-1079 Year: 2010
Incidence of hospitalized all-cause pneumonia, and serotype distribution of hospitalized streptococcus pneumoniae pneumonia in Norway 2008-2009 Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013
Characteristics of patients with serotype 5 pneumococcal pneumonia Source: Virtual Congress 2020 – Clinical challenges in pneumonia Year: 2020
The remaining challenges of pneumococcal disease in adults Source: Eur Respir Rev 2012; 21: 57-65 Year: 2012
Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia Source: Eur Respir J 2015; 45: 1632-1641 Year: 2015
Pneumococcal carriage and serotypes distribution in patients with acute otitis media in Switzerland, 2004-2014 Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease Year: 2016
Clinical features of adults with seven-valent- conjugated-vaccine- serotype pneumococcal pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany Source: Eur Respir J, 59 (2) 2102432; 10.1183/13993003.02432-2021 Year: 2022
Impact of introducing the 10-valent pneumococcal conjugate vaccine on childhood hospitalizations for bacterial pneumonia in Brazil Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma Year: 2013
Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects Source: Eur Respir J 2005; 26: 1086-1091 Year: 2005
Clinical effectiveness of pneumococcal vaccination against nonbacteremic pneumonia in people over 50 years Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008
Serotype dynamics in pneumococcal diseases and the performance of vaccination strategies for older adults in germany Source: Virtual Congress 2020 – How do different treatment strategies translate into costs Year: 2020
Evolution of antimicrobial resistance trends in the last five years in patients with bacteremic Pneumococcal community-acquired pneumonia (CAP-SP) Source: Eur Respir J 2005; 26: Suppl. 49, 639s Year: 2005
Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden Source: Eur Respir J 2016; 47: 1208-1218 Year: 2016
Increasing prevalence of complicated pneumonia and pneumococcal related hemolytic uremic syndrome despite territory-wide program of pneumococcal conjugated vaccination (PCV-7) program in children Source: International Congress 2014 – Paediatric epidemiology: wheeze, asthma and other respiratory diseases Year: 2014
Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis Year: 2017
Dynamics of serotypic composition of nasopharyngeal pneumococcal isolates in children pneumococcal nasopharyngeal colonization after the introduction of the vaccination program in Moscow Source: Virtual Congress 2020 – Different aspects of paediatric viral and bacterial lung infections Year: 2020